Autolus Therapeutics (AUTL)

• Market cap: $508M
• 1 day: -2.05%
• 5 days: -6.37%
• 1 month: 20.13%
• 3 months: 8.52%
• 6 months: -19.07%
• Year to date: 2.14%
• 1 year: -20.75%
• 5 years: -79.42%
• 10 years: -92.36%
• Sector: Healthcare
• Industry: Biotechnology

About: Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Employees: 647